Volume 239, Issue 6

Search all Psychopharmacology articles

June 2022

Special Issue on Psychopharmacology on Psychedelic Drugs

Issue Editors:

Harriet Wit,
Deepak Cyril D’Souza

25 articles in this issue

Psychedelics: Old trips, new destinations in psychopharmacology research
Harriet de Wit
Deepak Cyril D’Souza
Editorial 23 April 2022 Pages: 1643 - 1645
Correction to: Psychedelics: Old trips, new destinations in psychopharmacology research
Harriet de Wit
Deepak Cyril D’Souza
Correction 11 May 2022 Pages: 1647 - 1647
Sex-specific effects of psychedelics on prepulse inhibition of startle in 129S6/SvEv mice
Hiba Z. Vohra
Justin M. Saunders
Javier González-Maeso
Original Investigation 04 August 2021 Pages: 1649 - 1664
Effects of the 5-HT_2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents
Alaina M. Jaster
Harrison Elder
Javier González-Maeso
Original Investigation 02 March 2022 Pages: 1665 - 1677
Role of 5-HT_2A receptors in the effects of ayahuasca on ethanol self-administration using a two-bottle choice paradigm in male mice
Yasmim A. Serra
Thaísa Barros-Santos
Eduardo A. V. Marinho
Original Investigation 07 March 2022 Pages: 1679 - 1687
Effects of ketamine optical isomers, psilocybin, psilocin and norpsilocin on time estimation and cognition in rats
Piotr Popik
Adam Hogendorf
Joanna Golebiowska
Original Investigation Open access 02 March 2022 Pages: 1689 - 1703
Effects of psilocybin microdosing on awe and aesthetic experiences: a preregistered field and lab-based study
Michiel van Elk
George Fejer
Josephine Marschall
Original Investigation Open access 30 April 2021 Pages: 1705 - 1720
Low-dose LSD and the stream of thought: Increased Discontinuity of Mind, Deep Thoughts and abstract flow
Isabel Wießner
Marcelo Falchi
Luís Fernando Tófoli
Original Investigation 28 October 2021 Pages: 1721 - 1733
Low doses of LSD reduce broadband oscillatory power and modulate event-related potentials in healthy adults
Conor H. Murray
Ilaria Tare
Harriet de Wit
Original Investigation 06 October 2021 Pages: 1735 - 1747
Administration of N,N-dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT
Steven A. Barker
Review 22 January 2022 Pages: 1749 - 1763
Correction to: Administration of N,N‑dimethyltryptamine (DMT) in psychedelic therapeutics and research and the study of endogenous DMT
Steven A. Barker
Correction 11 February 2022 Pages: 1765 - 1765
Ayahuasca and tobacco smoking cessation: results from an online survey in Brazil
Dimitri Daldegan-Bueno
Lucas Oliveira Maia
Luís Fernando Tófoli
Original Investigation 18 February 2022 Pages: 1767 - 1782
The use patterns of novel psychedelics: experiential fingerprints of substituted phenethylamines, tryptamines and lysergamides
P. Mallaroni
N. L. Mason
J. G. Ramaekers
Original Investigation Open access 30 April 2022 Pages: 1783 - 1796
Differential contributions of serotonergic and dopaminergic functional connectivity to the phenomenology of LSD
Timothy Lawn
Ottavia Dipasquale
Matthew A. Howard
Original Investigation Open access 24 March 2022 Pages: 1797 - 1808
Do psychedelics change beliefs?
H. T. McGovern
P. Leptourgos
P. R. Corlett
Theoretical and Methodological Perspective 04 May 2022 Pages: 1809 - 1821
The role of serotonin neurotransmission in rapid antidepressant actions
A. L. Pehrson
D. Roberts
R. McNair
Review 25 March 2022 Pages: 1823 - 1838
Therapeutic effect of an ayahuasca analogue in clinically depressed patients: a longitudinal observational study
Kim van Oorsouw
S. W. Toennes
J. G. Ramaekers
Original Investigation Open access 24 January 2022 Pages: 1839 - 1852
How to account for hallucinations in the interpretation of the antidepressant effects of psychedelics: a translational framework
Manon van den Berg
Igor Magaraggia
Joseph H. Porter
Theoretical and Methodological Perspective Open access 29 March 2022 Pages: 1853 - 1879
Serotonin toxicity of serotonergic psychedelics
Benjamin Malcolm
Kelan Thomas
Review 12 July 2021 Pages: 1881 - 1891
Safety pharmacology of acute LSD administration in healthy subjects
Friederike Holze
Toya V. Caluori
Matthias E. Liechti
Original Investigation Open access 13 September 2021 Pages: 1893 - 1905
Assessing the risk–benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research
David Bender
David J. Hellerstein
Review 13 January 2022 Pages: 1907 - 1932
Flashback phenomena after administration of LSD and psilocybin in controlled studies with healthy participants
Felix Müller
Elias Kraus
Stefan Borgwardt
Original Investigation Open access 25 January 2022 Pages: 1933 - 1943
Drug-drug interactions between psychiatric medications and MDMA or psilocybin: a systematic review
Aryan Sarparast
Kelan Thomas
Christopher S. Stauffer
Review 07 March 2022 Pages: 1945 - 1976
The adverse events of ibogaine in humans: an updated systematic review of the literature (2015–2020)
Genís Ona
Juliana Mendes Rocha
Rafael G. dos Santos
Review 18 August 2021 Pages: 1977 - 1987
Great Expectations: recommendations for improving the methodological rigor of psychedelic clinical trials
Jacob S. Aday
Boris D. Heifets
Joshua D. Woolley
Review 01 April 2022 Pages: 1989 - 2010

Volume 239, Issue 6

Search

Navigation